Trial Profile
A phase II, proof-of-concept trial of TCN 032 in hospitalised patients with serious influenza infection
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 15 Sep 2012
Price :
$35
*
At a glance
- Drugs TCN 032 (Primary)
- Indications Influenza A virus infections
- Focus Therapeutic Use
- 15 Sep 2012 New trial record